Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Clinical

RSS  

Articles

  • Serial Biomarkers in Heart Failure

    Biomarkers such as brain natriuretic peptides (BNP) and troponin have been shown to be of diagnostic and prognostic value in patients with heart failure, but little is known abut the value of serial outpatient measurements.
  • Beta-Blockers for Asymptomatic Left Ventricular Systolic Dysfunction

    Asymptomatic individuals with systolic left ventricular (LV) dysfunction have an increased mortality. Angiotensin converting enzymes inhibitors (ACEI) and angiotensin receptor blockers (ARB) favorably affect such patients, but little is known abut the effect of beta-blockers in this group.
  • Clinical Briefs in Primary Care Supplement

  • Pharmacology Watch

    Patients with peripheral artery disease are at high risk for cardiovascular complications. Antiplatelet drugs are routinely prescribed for these patients, but is adding an oral anticoagulant of value?
  • Vulnerable Plaques by CT

    The increasing use of 64-slice computed tomography or MSCT is beginning to significantly impact the medical literature.
  • Management of Ventricular Arrhythmias in ARVD/C

    Dalal and his colleagues describe data from the Johns Hopkins Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) registry concerning the efficacy of catheter ablation for ventricular tachycardia (VT) in this condition.
  • ICDs for HCM

    This report describes a large group of patients with hypertrophic cardiomyopathy (HCM) who underwent implantable cardioverter defibrillator (ICD) implantation at 42 referral and nonreferral institutions in the United States, Europe and Australia.
  • Aliskiren and Valsartan for Hypertension

    Aliskiren is a new class of drugs that directly inhibit renin and is approved in the U.S.A. for the treatment of hypertension. Valsartan is the best selling antihypertensive medication in the world.
  • Neonatal and Five Year Outcomes after Birth at 30-34 Weeks of Gestation

    In the latest issue of Obstetrics and Gynecology there were 3 papers, loosely tied together, that should provide important guidance to clinicians dealing with preterm labor (PTL). One article will be the source for the primary review, but the others will be folded into the comments sections.
  • Dietary Intake and Prognosis after Breast Cancer

    Results of the Women's Healthy Eating and Living (WHEL) study were published in a recent issue of JAMA. In this multicenter, randomized controlled trial a total of 3088 women diagnosed with early-stage breast cancer (stage I-IIIa) within the previous four years were randomized to a diet rich in vegetables, fruit and fiber and low in fat, vs a regular diet.